These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1676448)

  • 1. CSF S-adenosylmethionine in neuropsychiatric disorders.
    Bottiglieri T; Reynolds EH; Toone BK; Carney MW
    Lancet; 1991 Jul; 338(8759):121. PubMed ID: 1676448
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine.
    Bottiglieri T; Godfrey P; Flynn T; Carney MW; Toone BK; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1096-8. PubMed ID: 2292704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-adenosylmethionine levels in psychiatric and neurological disorders: a review.
    Bottiglieri T; Hyland K
    Acta Neurol Scand Suppl; 1994; 154():19-26. PubMed ID: 7524260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF somatostatin in Alzheimer's disease, depressed patients, and control subjects.
    Davis KL; Davidson M; Yang RK; Davis BM; Siever LJ; Mohs RC; Ryan T; Coccaro E; Bierer L; Targum SD
    Biol Psychiatry; 1988 Oct; 24(6):710-2. PubMed ID: 2901865
    [No Abstract]   [Full Text] [Related]  

  • 5. S-adenosylmethionine influences monoamine metabolism.
    Bottiglieri T; Laundy M; Martin R; Carney MW; Nissenbaum H; Toone BK; Johnson AL; Reynolds EH
    Lancet; 1984 Jul; 2(8396):224. PubMed ID: 6146777
    [No Abstract]   [Full Text] [Related]  

  • 6. The transmethylation cycle in the brain of Alzheimer patients.
    Mulder C; Schoonenboom NS; Jansen EE; Verhoeven NM; van Kamp GJ; Jakobs C; Scheltens P
    Neurosci Lett; 2005 Sep; 386(2):69-71. PubMed ID: 16040194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's disease.
    Arlt S; Schwedhelm E; Kölsch H; Jahn H; Linnebank M; Smulders Y; Jessen F; Böger RH; Popp J
    J Alzheimers Dis; 2012; 31(4):751-8. PubMed ID: 22710910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebrospinal fluid levels of leucine enkephalin and methionine enkephalin in patients with altered behavior].
    Loeb C; Albano C; Serrati C
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 134(1):29-40. PubMed ID: 6231720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid.
    Smith DE; Smulders YM; Blom HJ; Popp J; Jessen F; Semmler A; Farkas M; Linnebank M
    Clin Chem Lab Med; 2012 Mar; 50(9):1641-7. PubMed ID: 22962226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.
    Sunderland T; Rubinow DR; Tariot PN; Cohen RM; Newhouse PA; Mellow AM; Mueller EA; Murphy DL
    Am J Psychiatry; 1987 Oct; 144(10):1313-6. PubMed ID: 2889377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency.
    Hyland K; Smith I; Bottiglieri T; Perry J; Wendel U; Clayton PT; Leonard JV
    Neurology; 1988 Mar; 38(3):459-62. PubMed ID: 3347350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-3,4-dihydroxyphenylalanine (levodopa) lowers central nervous system S-adenosylmethionine concentrations in humans.
    Surtees R; Hyland K
    J Neurol Neurosurg Psychiatry; 1990 Jul; 53(7):569-72. PubMed ID: 2391519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression.
    Hoogendijk WJ; Meynen G; Endert E; Hofman MA; Swaab DF
    Neurobiol Aging; 2006 May; 27(5):780.e1-780.e2. PubMed ID: 16198445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment.
    Gonzales MM; Insel PS; Nelson C; Tosun D; Schöll M; Mattsson N; Sacuiu S; Bickford D; Weiner MW; Mackin RS;
    Int J Geriatr Psychiatry; 2018 Oct; 33(10):1305-1311. PubMed ID: 29953668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers trump behavior in mental illness diagnosis.
    Haag AL
    Nat Med; 2007 Jan; 13(1):3. PubMed ID: 17206108
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals.
    Deutsch SI; Mohs RC; Levy MI; Rothpearl AB; Stockton D; Horvath T; Coco A; Davis KL
    Biol Psychiatry; 1983 Dec; 18(12):1363-73. PubMed ID: 6661467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease.
    Popp J; Lewczuk P; Linnebank M; Cvetanovska G; Smulders Y; Kölsch H; Frommann I; Kornhuber J; Maier W; Jessen F
    J Alzheimers Dis; 2009; 18(4):819-28. PubMed ID: 19661622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF-studies in neuropsychiatric disorders.
    Raedler TJ; Wiedemann K
    Neuro Endocrinol Lett; 2006 Jun; 27(3):297-305. PubMed ID: 16807525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection: effect of parenteral treatment with SAMe.
    Castagna A; Le Grazie C; Accordini A; Giulidori P; Cavalli G; Bottiglieri T; Lazzarin A
    Neurology; 1995 Sep; 45(9):1678-83. PubMed ID: 7675226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway.
    Surtees R; Leonard J; Austin S
    Lancet; 1991 Dec 21-28; 338(8782-8783):1550-4. PubMed ID: 1683972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.